The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Year of Diagnosis, Features at Presentation, and Risk of Recurrence in Patients with Pheochromocytoma or Secreting Paraganglioma
Abstract
Pheochromocytoma or secreting paraganglioma may recur after initial surgery. Diagnostic methods have improved in recent decades. We determined whether features at presentation have changed over time and are associated with long-term outcome. In 192 patients with pheochromocytoma/paraganglioma seen between 1975 and 2003, we compared time from onset of hypertension to first operation, total metanephrine excretion, tumor size and site, the proportion of cases presenting as incidentalomas, and the probability of recurrence according to date of operation (divided into quartiles). The duration of hypertension and tumor size at first operation decreased significantly over time. Right-sided adrenal tumors were more frequent and larger, excreted greater amounts of metanephrines, and presented more frequently as incidentalomas than left-sided tumors. Age, familial disease, and tumor site and size were independent predictors of recurrence. The risk of recurrence was 3.4-fold higher in patients with familial disease than in those with sporadic tumors; it was, respectively, 3.1- and 11.2-fold higher in patients with right adrenal and extraadrenal tumors than in patients with left adrenal tumors. In conclusion, pheochromocytomas/paragangliomas can now be diagnosed earlier, with smaller tumors, and more frequently as incidentalomas. Familial, right adrenal, and extraadrenal tumors recur more frequently than left adrenal tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Reporting results of cancer treatment
Miller, A. B., Hoogstraten, B., Staquet, M., & Winkler, A. (1981) · Cancer · doi:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 · Cited by 7,793
(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
Biochemical Diagnosis of Pheochromocytoma: Which Test Is Best?
Lenders, J. W. M., Pacak, K., Walther, M. M., Linehan, W. M., Mannelli, M., Friberg, P., Keiser, H. R., Goldstein, D. S., & Eisenhofer, G. (2002) · JAMA · doi:10.1001/jama.287.11.1427 · Cited by 1,134
Management of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945 · cited 1×
“Presymptomatic diagnosis is possible in patients with phenotypic evidence or family history of a genetic disease that is associated with PHEO/PGL (1–4) and in patients with incidentally discovered adrenal masses, the so-called incidentalomas (10).”
BackgroundNeumann, H. P. H. (2004) · JAMA · doi:10.1001/jama.292.8.943 · Cited by 893
Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma
Pacak, K., Linehan, W. M., Eisenhofer, G., Walther, M. M., & Goldstein, D. S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-4-200102200-00016 · Cited by 618
Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.
Gimenez‐Roqueplo, A., Favier, J., Rustin, P., Rieubland, C., Crespin, M., Nau, V., Kien, P. K. V., Corvol, P. L., Plouin, P., & Jeunemaître, X. (2003) · PubMed · Cited by 609
Self-citationPheochromocytoma: State-of-the-Art and Future Prospects
Bravo, E. L., & Tagle, R. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0013 · Cited by 493
Clinical Experience Over 48 Years With Pheochromocytoma
Goldstein, R. E., O’Neill, J. A., Holcomb, G. W., Morgan, W. M., Neblett, W. W., Oates, J. A., Brown, N., Nadeau, J., Smith, B., Page, D. L., et al. (1999) · Annals of Surgery · doi:10.1097/00000658-199906000-00001 · Cited by 464
Ilona Linnoila, R., Keiser, H. R., Steinberg, S. M., & Lack, E. E. (1990) · Human Pathology · doi:10.1016/0046-8177(90)90155-x · Cited by 374
Current Management of Pheochromocytoma
REMINE, W. H., CHONC, G. C., VAN HEERDEN, J. A., SHEPS, S. G., & HARRISON, E. G. (1974) · Annals of Surgery · doi:10.1097/00000658-197405000-00029 · Cited by 299
Pheochromocytomas: can malignant potential be predicted?
John, H., Ziegler, W. H., Hauri, D., & Jaeger, P. (1999) · Urology · doi:10.1016/s0090-4295(98)00612-8 · Cited by 251
Pheochromocytoma in Italy: a multicentric retrospective study
Mannelli, M., Ianni, L., Cilotti, A., & Conti, A. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410619 · Cited by 228
Pheochromocytoma in Sweden 1958-1981. An analysis of the National Cancer Registry Data.
Stenström, G., & Svardsudd, K. F. (1986) · PubMed · Cited by 212
Plouin, P.-F., Duclos, J.-M., Soppelsa, F., Boublil, G., & Chatellier, G. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7392 · Cited by 201
Self-citationClinical Spectrum and Outcome of Functional Extraadrenal Paraganglioma
O’Riordain, D. S., Young, W. F., Grant, C. S., Carney, J. A., & van Heerden, J. A. (1996) · World Journal of Surgery · doi:10.1007/s002689900139 · Cited by 201
Turnover and Metabolism of Catecholamines in Patients with Pheochromocytoma*
Crout, J. R., & Sjoerdsma, A. (1964) · Journal of Clinical Investigation · doi:10.1172/jci104898 · Cited by 200
Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma
Lee, J. E., Curley, S. A., Gagel, R. F., Evans, D. B., & Hickey, R. C. (1996) · Surgery · doi:10.1016/s0039-6060(96)80056-0 · Cited by 184
Phaeochromocytomas in 72 patients: Clinical and diagnostic features, treatment and long term results
Modlin, I. M., Farndon, J. R., Shepherd, A., Johnston, I. D. A., Kennedy, T. L., Montgomery, D. A. D., & Welbourn, R. B. (1979) · Journal of British Surgery · doi:10.1002/bjs.1800660704 · Cited by 176
Angiogenesis and Vascular Architecture in Pheochromocytomas
Favier, J., Plouin, P., Corvol, P. L., & Gasc, J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64400-8 · Cited by 164
Self-citationSUCCESSFUL OUTCOMES IN PHEOCHROMOCYTOMA SURGERY IN THE MODERN ERA
ULCHAKER, J. C., GOLDFARB, D. A., BRAVO, E. L., & NOVICK, A. C. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61762-2 · Cited by 162
Diabetes as a marker of pheochromocytoma in hypertensive patients
Batide-Alanore, A. L., Châtellier, G., & Plouin, P. (2003) · Journal of Hypertension · doi:10.1097/00004872-200309000-00020 · Cited by 157
Self-citationLoss of NF1 alleles in phaeochromocytomas from patients with type 1 neurofibromatosis
Xu, W., Mulligan, L. M., Ponder, M. A., Liu, L., Ponder, B. A. J., Smith, B. A., & Mathew, C. G. (1992) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870040411 · Cited by 155
Long‐term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s)
van Heerden, J. A., Roland, C. F., Carney, J. A., Sheps, S. G., & Grant, C. S. (1990) · World Journal of Surgery · doi:10.1007/bf01658516 · Cited by 146
Plouin, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.4.1480 · Cited by 146
Self-citationMALIGNANT PHAEOCHROMOCYTOMA: CLINICAL, BIOCHEMICAL AND SCINTIGRAPHIC CHARACTERIZATION
Shapiro, B., Sisson, J. C., LLOYD, R., Nakajo, M., SATTERLEE, W. G., & Beierwaltes, W. H. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb00074.x · Cited by 131
Pheochromocytoma--continuing evolution of surgical therapy.
Orchard, T. J., Grant, C. S., van Heerden, J. A., & Weaver, A. L. (1993) · PubMed · Cited by 108
Pheochromocytoma: Study of 50 Cases
Lucón, A. M., Pereira, M. A. A., Mendonca, B. B., Halpern, A., Wajchenbeg, B. L., & Arap, S. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)64925-5 · Cited by 99
Oncologic aspects of pheochromocytoma: the importance of follow-up.
Hw, S., & Halter, S. A. (1984) · PubMed · Cited by 98
The Urinary Metanephrine-to-Creatinine Ratio for the Diagnosis of Pheochromocytoma
Héron, E., Châtellier, G., Billaud, E., et al. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-4-199608150-00008 · Cited by 89
Favia, G., Lumachi, F., Polistina, F., et al. (1998) · World Journal of Surgery · doi:10.1007/s002689900454 · Cited by 53
Production, characterization, and expression of neuropeptide Y by human pheochromocytoma.
Senanayake, P. D., Denker, J., Bravo, E. L., & Graham, R. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118310 · Cited by 48
Feldman, J. M., BLALOCK, J. A., Zern, R. T., & Wells, S. A. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-49-3-445 · Cited by 46
Diagnosis and treatment of adrenal tumours: a review of 35 years’ experience
Xiao, X., Ye, X., Shi, S., Cheng, C., LI, & Zhou (1998) · British Journal of Urology · doi:10.1046/j.1464-410x.1998.00726.x · Cited by 43
Morphological Analysis of Adrenal Glands: A Prospective Analysis
Lam, K.-Y., Chan, A. C.-L., & Lo, C. (2001) · Endocrine Pathology · doi:10.1385/ep:12:1:33 · Cited by 27
Lumachi, F., Polistina, F., Favia, G., et al. (1998) · PubMed · Cited by 9
Cited by
Calhoun, D. A., Jones, D., Textor, S., Goff, D. C., Murphy, T. P., Toto, R. D., White, A., Cushman, W. C., White, W., Sica, D., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.189141 · Cited by 2,237
Lenders, J. W., Eisenhofer, G., Mannelli, M., & Pacak, K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67139-5 · Cited by 1,524
Calhoun, D. A., Jones, D., Textor, S., Goff, D. C., Murphy, T. P., Toto, R. D., White, A., Cushman, W. C., White, W., Sica, D., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.189141 · Cited by 1,413
Pheochromocytoma and Paraganglioma
Neumann, H. P. H., Young, W. F., & Eng, C. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1806651 · Cited by 736
Genetic Testing in Pheochromocytoma or Functional Paraganglioma
Amar, L., Bertherat, J., Baudin, E., Ajzenberg, C., Bressac-de Paillerets, B., Chabre, O., Chamontin, B., Delemer, B., Giraud, S., Murat, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1484 · Cited by 684
Self-citation
Metadata
- Authors
- Amar, L., Servais, A., Gimenez-Roqueplo, A.-P., Zinzindohoue, F., Chatellier, G., & Plouin, P.-F.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-04
- Volume
- 90
- Issue
- 4
- Pages
- 2110-2116
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1982938784
- Cited by
- 390
- References
- 40
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.